Dolby Laboratories (DLB) Net Income towards Common Stockholders (2009 - 2026)
Dolby Laboratories' (DLB) quarterly Net Income towards Common Stockholders came in at $29.2 million in Q2 2026, down 37.22% YoY from $46.5 million in Q2 2025, and down 69.41% on a QoQ basis from $95.5 million in Q1 2026.
Dolby Laboratories (DLB) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Dolby Laboratories (DLB) has 18 years of Net Income towards Common Stockholders data on file, last reported at $29.2 million in Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 37.22% year-over-year to $29.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $228.0 million (down 14.17% YoY) and the FY2025 annual result came in at $256.5 million, down 2.96% from the prior year.
- Net Income towards Common Stockholders fell to $29.2 million in Q2 2026, from $95.5 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $98.2 million in Q1 2024 to a low of $9.9 million in Q3 2023.
- A 5-year average of $55.8 million and a median of $51.7 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders plunged 64.29% — and 2024, when it jumped 493.22%.
- Tracing DLB's Net Income towards Common Stockholders over 5 years: stood at $79.4 million in 2022, then retreated by 15.0% to $67.5 million in 2023, then grew by 0.77% to $68.1 million in 2024, then slipped by 21.12% to $53.7 million in 2025, then tumbled by 45.6% to $29.2 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $29.2 million (Q2 2026), $95.5 million (Q1 2026), and $53.7 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.69 Bn | 81.40 Bn | 1.48 Bn | 510.99 Mn |
| 2 | Relx | 64.97 Bn | 64.80 Bn | - | - |
| 3 | Copart | 32.09 Bn | 28.74 Bn | 732.88 Mn | 401.39 Mn |
| 4 | Global Payments | 24.80 Bn | 19.40 Bn | 2.03 Bn | 7.25 Mn |
| 5 | Rb Global | 16.24 Bn | 15.72 Bn | 935.50 Mn | 132.00 Mn |
| 6 | Aramark | 15.68 Bn | 15.18 Bn | 430.34 Mn | 97.83 Mn |
| 7 | UL Solutions | 15.20 Bn | 14.77 Bn | 417.00 Mn | 254.00 Mn |
| 8 | Rentokil Initial | 11.80 Bn | 9.27 Bn | - | - |
| 9 | Dolby Laboratories | 6.05 Bn | 5.38 Bn | 264.68 Mn | 29.20 Mn |
| 10 | Unifirst | 5.23 Bn | 5.06 Bn | 234.73 Mn | 19.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 29.20 Mn |
| Mar 27, 2026 | 95.50 Mn |
| Dec 26, 2025 | 53.68 Mn |
| Sep 26, 2025 | 49.65 Mn |
| Jun 27, 2025 | 46.54 Mn |
| Mar 28, 2025 | 92.23 Mn |
| Dec 27, 2024 | 68.07 Mn |
| Sep 27, 2024 | 58.87 Mn |
| Jun 28, 2024 | 39.66 Mn |
| Mar 29, 2024 | 98.25 Mn |
| Dec 29, 2023 | 67.58 Mn |
| Sep 29, 2023 | 9.92 Mn |
| Jun 30, 2023 | 16.41 Mn |
| Mar 31, 2023 | 95.88 Mn |
| Dec 30, 2022 | 79.45 Mn |
| Sep 30, 2022 | 27.76 Mn |
| Jul 1, 2022 | 39.61 Mn |
| Apr 1, 2022 | 36.55 Mn |
| Dec 31, 2021 | 80.01 Mn |
| Sep 24, 2021 | 44.23 Mn |